The Washington Report

June 19, 2024

Note to Subscribers

While we do our best to provide timely updates, it is possible that the information shared in the newsletter may change after our publication deadline.

Aon Publications

Supreme Court Strikes Down Challenge to FDA’s Approval of Mifepristone
On June 13, 2024, the U.S. Supreme Court held that plaintiffs challenging the Food and Drug Administration’s (FDA’s) approval and regulation of mifepristone did not have standing to challenge the FDA’s actions regarding mifepristone, leaving the FDA’s current approval and regulation of mifepristone unchanged.

The Aon bulletin is available here.